Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
We will read the comment and provide high-quality battery knowledge tutorial
It is currently the only compound of its kind that has received FDA approval (under the name Vyleesi) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, further highlighting its importance as a research molecule
Science, 372(6547), 12241229
10.1016/S0167-0115(99)00089-0 2
Pharmacological inhibition of cystineglutamate exchange induces endoplasmic reticulum stress and ferroptosis
US$ 27.43
US$ 26.77
US$ 25.03
US$ 21.15
US$ 22.30
US$ 29.24
